We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
-$668M
Cap. Flow
+$51.1M
Cap. Flow %
1.72%
Top 10 Hldgs %
63.58%
Holding
795
New
186
Increased
196
Reduced
157
Closed
179

Top Buys

1
MSFT icon
Microsoft
MSFT
+$120M
2
LLY icon
Eli Lilly
LLY
+$117M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$70.3M
4
AMZN icon
Amazon
AMZN
+$16.6M
5
PLTR icon
Palantir
PLTR
+$16.1M

Top Sells

1
META icon
Meta Platforms (Facebook)
META
+$239M
2
RNAM
Avidity Biosciences
RNAM
+$210M
3
AAPL icon
Apple
AAPL
+$183M
4
AMD icon
Advanced Micro Devices
AMD
+$98.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$91.7M

Sector Composition

1 Technology 35.38%
2 Financials 18.17%
3 Healthcare 16.24%
4 Consumer Discretionary 10.31%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.02T
$675M 22.74%
5,559,626
-245,742
-4% -$29M
COIN icon
2
Coinbase
COIN
$42.3B
$227M 7.65%
1,275,333
-213,642
-14% -$42.8M
META icon
3
Meta Platforms (Facebook)
META
$1.69T
$177M 5.97%
309,820
-463,835
-60% -$239M
AMZN icon
4
Amazon
AMZN
$2.69T
$143M 4.83%
769,822
+90,736
+13% +$16.6M
MSFT icon
5
Microsoft
MSFT
$2.98T
$141M 4.74%
327,257
+280,640
+602% +$120M
PTCT icon
6
PTC Therapeutics
PTCT
$6.51B
$133M 4.49%
3,590,655
-165,814
-4% -$5.55M
AAPL icon
7
Apple
AAPL
$4.89T
$122M 4.11%
523,959
-820,528
-61% -$183M
LLY icon
8
Eli Lilly
LLY
$1.04T
$116M 3.89%
+130,399
New +$117M
TSLA icon
9
Tesla
TSLA
$1.47T
$80.7M 2.72%
308,553
+69,169
+29% +$15.8M
TARS icon
10
Tarsus Pharmaceuticals
TARS
$2.52B
$72.3M 2.43%
2,197,385
– –
GOOGL icon
11
Alphabet (Google) Class A
GOOGL
$4.33T
$69.5M 2.34%
+419,077
New +$70.3M
BABA icon
12
Alibaba
BABA
$282B
$67M 2.26%
631,199
+106,573
+20% +$8.72M
AMD icon
13
Advanced Micro Devices
AMD
$817B
$52M 1.75%
317,107
-650,124
-67% -$98.8M
STOK icon
14
Stoke Therapeutics
STOK
$1.81B
$39.9M 1.34%
3,244,498
-121,246
-4% -$1.72M
ESTA icon
15
Establishment Labs
ESTA
$2.72B
$37.6M 1.27%
869,948
-70,000
-7% -$3.04M
NKLA
16
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
$33.7M 1.14%
1,245,900
+841,000
+208% +$6.23M
ET icon
17
Energy Transfer Partners
ET
$69.5B
$30.4M 1.03%
1,897,000
+70,000
+4% +$1.13M
ANSC
18
Agriculture & Natural Solutions Acquisition Corp
ANSC
$475M
$23.3M 0.78%
2,246,381
+272,702
+14% +$2.81M
URGN icon
19
UroGen Pharma
URGN
$1.95B
$22.8M 0.77%
1,796,589
-302,893
-14% -$4.5M
MERC icon
20
Mercer International
MERC
$44.9M
$22.3M 0.75%
3,300,000
– –
KDK
21
Kodiak AI
KDK
$825M
$21.3M 0.72%
1,963,091
-1,345,140
-41% -$14.5M
RCKT icon
22
Rocket Pharmaceuticals
RCKT
$372M
$20.3M 0.68%
1,100,000
– –
SMFG icon
23
Sumitomo Mitsui Financial
SMFG
$164B
$19.7M 0.66%
1,560,230
-1,240,500
-44% -$16.4M
PLTR icon
24
Palantir
PLTR
$322B
$19.5M 0.66%
+523,644
New +$16.1M
STHO icon
25
Star Holdings Shares of Beneficial Interest
STHO
$114M
$18.3M 0.62%
1,324,301
+4,705
+0.4% +$61K
1
2 3 4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2024 Portfolio in Review

As of Q3 2024, Cowen and Company held 795 positions worth $2.97B, down 18% from $3.64B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cowen and Company's Q3 2024 filing shows 186 new, 196 increased, 157 reduced and 179 closed positions. Its largest new stake was Eli Lilly: 130,399 shares worth $116M. The largest sale was Meta Platforms (Facebook), an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Cowen and Company's largest Q3 2024 buy was Eli Lilly: 130,399 shares worth $116M.
  • Cowen and Company added most to Microsoft in Q3 2024, an estimated $120M increase.
  • Cowen and Company's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $239M.
  • Cowen and Company fully exited Avidity Biosciences in Q3 2024, selling an estimated $210M.
  • Cowen and Company's ten largest holdings make up 64% of its $2.97B portfolio in Q3 2024.
  • Cowen and Company opened 186 new positions and closed 179 in Q3 2024.
  • Cowen and Company's portfolio value fell 18% quarter-over-quarter to $2.97B.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.